13797-77-8

Basic information

• Product Name: 5-METHOXYPYRIDOó3,2-D]ó1,3]THIAZOL-2-AMINE,97%
• Synonyms: 5-METHOXYPYRIDOó3,2-D]ó1,3]THIAZOL-2-AMINE,97%;5-methoxypyrido[3,2-d][1,3]thiazol-2-amine;5-METHOXY-THIAZOLO[5,4-B]PYRIDINE-2-AMINE;5-methoxythiazolo[5,4-b]pyridin-2-amine;5-Methoxy-thiazolo[5,4-b]pyridin-2-ylaMine;5-Methoxy[1,3]thiazolo[5,4-b]pyridin-2-amine
• CAS NO: 13797-77-8
• Molecular Formula: C₇H₇N₃OS
• Molecular Weight: 181.21498
• Mol File: 13797-77-8.mol
• Article Data: 19

Chemical Properties

• Melting Point: 193℃
• Appearance: /
• CAS DataBase Reference: 5-METHOXYPYRIDOó3,2-D]ó1,3]THIAZOL-2-AMINE,97%(CAS DataBase Reference)
• NIST Chemistry Reference: 5-METHOXYPYRIDOó3,2-D]ó1,3]THIAZOL-2-AMINE,97%(13797-77-8)
• EPA Substance Registry System: 5-METHOXYPYRIDOó3,2-D]ó1,3]THIAZOL-2-AMINE,97%(13797-77-8)

Safety Data

• Hazard Codes: Xi:Irritant
• Statements: R36/37/38:Irritating to eyes, respiratory system and skin.
• Safety Statements: S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.; S37/39:Wear suitable g
• Hazardous Substances Data: 13797-77-8(Hazardous Substances Data)

Usage

General Description

5-METHOXYPYRIDOó3,2-D]ó1,3]THIAZOL-2-AMINE,97% is a specialized chemical compound falling under the category of heterocyclic organic compounds. It is characterized by the presence of a pyrido-thiazolamine core, which is further modified by a methoxy group attached to the 5th carbon atom of the pyridine ring. The "97%" indicates its purity degree, suggesting that it consists of 97% of the specified compound and 3% of other impurities. Specific information about its physical properties, potential uses, and safety measures would typically be described in its material safety data sheet. However, such complex compounds are often used in various research and development contexts, particularly in drug discovery and synthetic chemistry processes.

Upstream product

• 6628-77-9 6-methoxy-pyridin-3-ylamine 
• 333-20-0 potassium thioacyanate 
• 505-14-6 thiocyanogen 
• 540-72-7 sodium thiocyanide 
• 13534-97-9 6-bromopyridine-3-amine 
• 67-56-1 methanol 
• 1147550-11-5 ammonium thiocyanate 
• 4548-45-2 2-chloro-5-nitropyridine 
• 38533-61-8 2-chloro-6-methoxy-3-nitropyridine 
• 17356-08-0 thiourea 
• 5446-92-4 2-methoxy-5-nitropyridine 

Downstream Products

• 81587-43-1 N-6'-methoxy-2'<1H>-thioxo-3'-pyridyl-2,4-dichloro-6-pyrimidinylamine 
• 42362-27-6 2,4-Diamino-6-(6-methoxy-2<1H>-thion-3-pyridyl)pyrimidinylamin 
• 1445883-67-9 C₁₄H₈N₄O₃S 
• 1445883-68-0 C₂₀H₁₉N₅O₄S 
• 1445883-69-1 C₂₀H₂₁N₅O₂S 
• 1445881-84-4 C₂₈H₃₁N₇O₄S 
• 214337-35-6 2-bromo-5-methoxy-thiazolo[5,4-b]pyridine 
• 1415798-36-5 N-(4-(2-amino-3-chloropyridine-4-oxy)-3-fluorophenyl)-2-(dimethylamino)-4-(4-fluorophenyl)-5-oxo-4,5-dihydro-thiazolo[5,4-b]pyridine-6-formamide 
• 1415797-93-1 2-(dimethylamino)-4-(4-fluorophenyl)-5-oxo-4,5-dihydrothiazolo[5,4-b]pyridine-6-formic acid 
• 1415797-92-0 methyl 2-(dimethylamino)-4-(4-fluorophenyl)-5-oxo-4,5-dihydrothiazolo[5,4-b]pyridine-6-formate 

Relevant articles and documents

-

-

Polymerizable compound, polymerizable composition, polymer, and optically anisotropic material

The present invention relates to: a polymerizable compound (I), wherein Y1 to Y6 are a chemical single bond, —O—C(═O)—, —C(═O)—O— or the like, G1 and G2 are a divalent aliphatic group, Z1 and Z2 are an alkenyl group, Ax is a fused ring group represented by a formula (II), wherein X is —NR3—, an oxygen atom, a sulfur atom or the like, R3 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and D is a substituted or unsubstituted ring having 1 to 20 carbon atoms that includes at least one nitrogen atom, Ay is a hydrogen atom, an alkyl group, A1 is a trivalent aromatic group or the like, A2 and A3 are a divalent aromatic group having 6 to 30 carbon atoms or the like, and Q1 is a hydrogen atom, or an alkyl group having 1 to 6 carbon atoms.

7-HYDROXY-SPIROPIPIPERIDINE INDOLINYL ANTAGONISTS OF P2Y1 RECEPTOR

The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are antagonists of Ρ2Y1 receptor and may be used as medicaments in the treatment and/or prophylaxis of thromboembolic disorders.